The use is reported of the AngioVac system to resolve a case of persistent bacteremia in the setting of MRSA tricuspid valve infective endocarditis. The infection was secondary to intravenous drug use in a patient who had failed multiple antibiotic regimens and was deemed a poor surgical candidate.
How to cite: Wallenhorst, P., Rutland, J., Gurley, J., & Guglin, M. (2018). Use of AngioVac for Removal of Tricuspid Valve Vegetation. The Journal of heart valve disease, 27(1), 120–123.